tirzepatide triple agonist LY3437943, a novel glucagon, GIP, and GLP-1 receptor for glycemic control and weight loss: From discovery to clinical proof of concept retatrutide triple agonist glp-1 gip

J Agric Food Chem 63(14):36153626

This holiday season, Elon Musk is calling himself Ozempic Santa. Adorned in a Santa suit in a photo posted to X, the Tesla founder indicates hes taking one of the widely popular weight-loss drugs, known as GLP-1s, which are prescribed for those with Type 2 diabetes and obesity under brand names such as Ozempic, Mounjaro, Wegovy, and Zepbound

The drug was tested in over 9,500 adults with type 2 diabetes across at least 10 clinical trials

C.WeinheimerC

IQVIAs Post As semaglutide enters its off patent phase in multiple markets, the implications extend well beyond pricing

Enteric-coated peppermint oil capsules (0.2ml three times daily) provide more concentrated effects while preventing heartburn that pure peppermint oil can cause